PineDev
1 min read
VESA prediction tool could help guide presbyopia treatment
NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, AnnMarie Hipsley, DPT, PhD, founder and CEO of Ace Vision Group, speaks about the Virtual Eye Simulation Analyzer, a device with predictive diagnostic capabilities.
VESA uses ray tracing technology to analyze lens changes and biomechanics related to accommodation and disaccommodation, visualizing them in virtual reality and predicting near vision progression.
“This tool, once we are able to put it into effect, becomes a powerful prediction tool, which could guide presbyopia treatments,” Hipsley said.
Explore More Articles
Professor Marshall Continues to Propel Ace Vision Group Forward
Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering rejuvenation therapy for the aging eye, today announced that it has named John Marshall, PhD, FRCPath, FMedSc as Scientific Advisor of Laser Technology. Professor Marshall is a pioneer of laser eye surgery, having developed computer-controlled excimer lasers for the correction of …
read moreTHE ZOOMING EYE LENS: Effects of Age on Dynamic Range of Focus
DYNAMIC RANGE OF FOCUS (DRoF), or the total range of clear vision in a natural system, is an important biomechanical function of the accommodative apparatus responsible for adjusting the crystalline lens from both far to near (accommodation) and near to far (disaccommodation). DRoF is defined by true accommodation, pseudoaccommodation, and pupillary diaphragmatic changes, which work together …
read moreAce Vision Group Names Rob Kissling, MD, as Chief Medical Officer
Ace Vision Group announced that it has named Rob Kissling, MD, as Chief Medical Officer. Dr. Kissling has more than 20 years of experience integrating clinical development, medical strategy, and business planning to develop and commercialize devices and medicines for ophthalmology. His tenure has included companies such as Pharmacia, Pfizer, and Novartis. Most recently, he …
read more